We’re pleased to announce our partnership with Information Technology for Translational Medicine (ITTM). We have partnered to develop a prototype of a connector for transferring data from tranSMART to IPA for further analysis and back to tranSMART for visualization.
For more information about the connector and our partnership, please read the official press release from ITTM below.
ITTM and QIAGEN provide new tranSMART functionality
ITTM S.A. in partnership with QIAGEN
Boston, MA, April 6th, 2016
Information Technology for Translational Medicine, S.A. (ITTM S.A.) announced today that it has partnered with QIAGEN to develop the first prototype of a connector between tranSMART and Ingenuity Pathway Analysis (IPA®). The connector will be provided to the tranSMART Foundation to further strengthen the development of the tranSMART platform. tranSMART is a global open-source bio-medical knowledge management platform and the new application is available on the latest tranSMART version release 1.2.4.
Scientists who have access to both platforms will be able to transfer data from tranSMART to IPA® for further analysis. The results of the IPA Core Analysis are being transferred back to tranSMART for visualization. IPA® is a web-based software application for the analysis, integration, and interpretation of data derived from ‘omics experiments, such as RNAseq, small RNAseq, microarrays including miRNA and SNP, metabolomics, proteomics, and small- scale experiments that generate gene and chemical lists.
“We wanted to provide a flexible solution that fits the requirements of our pharma partners. We plan to further develop the prototype and to provide additional integration solutions for our customers in the future.” Dr. Andreas Kremer, Managing Director of ITTM S.A.
“This is a great example how one can use Ingenuity Pathway Analysis’ programming interfaces to integrate our unique and best in class content and interpretation capabilities in pathway analysis and genomics into a knowledge ecosystem covering other areas of knowledge”, said Dr. Frank Schacherer, VP for QIAGEN Bioinformatics.” ITTM has proven to be an excellent partner for tranSMART integration and customization.”
About ITTM S.A.
ITTM S.A. is a spin-off company of the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg. They provide data integration and knowledge management solutions and services to all bio-medical research areas. It focuses especially on translational medicine studies and clinical trials, in which heterogeneous data need to be curated, linked and integrated. ITTM S.A. offers cutting-edge clinical and multi-omics data analysis, visualization and text-mining solutions. For more information about ITTM, please visit the website at http://www.ittm-solutions.com.
About QIAGEN Redwood City
As QIAGEN’s Center of Excellence in Biological Analysis and Interpretation, QIAGEN Redwood, City (formerly Ingenuity Systems) is a leading provider of biomedical information and analysis solutions for the exploration, interpretation and analysis of complex biological systems in life science research and molecular diagnostics. These innovative solutions offered by QIAGEN are used by tens of thousands of researchers and clinicians at hundreds of leading pharmaceutical, biotechnology, academic, diagnostic and clinical institutions worldwide. Further information can be found at https://staging.digitalinsights.supremeclients.com.